Global and Japan PCR-based Enteric Disease Testing Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 21-Dec-2021
No. of pages: 128
Inquire Before Buying

Global PCR-based Enteric Disease Testing Scope and Market Size

PCR-based Enteric Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PCR-based Enteric Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Analyzers/Instruments

- Kits/Panels

Segment by Application

- Clostridium Difficile

- Campylobacteriosis

- Cholera

- E. coli Infection

- H. pylori Infection

- Salmonellosis

- Shigellosis

- Rotavirus Infection

- Norovirus Infection

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Thermo Fisher Scientific

- Vela Diagnostics

- CorisBioconcept

- Meridian Life Science

- Bio-Rad Laboratories

- Abbott (ALERE)

- bioMerieux SA

- Trinity Biotech

- DiaSorin Molecular

- Etta Healthcare (Ovagene Oncology)

- ExcitePCR (PositiveID Corporation)

- Flow Alliance

- Fluid-Screen

- FluimediX

- Fluxergy

- Focus Diagnostics (DiaSorin Molecular)

- Future Horizon Scientific

- Genalyte

- GeneFluidics

- GenSpeed Biotech

- Gulf Bio Analytical

- Hahn-Schickard

- Helvoet

- HemoCue

- Danaher

- IDEX Health&Science

- iLine Microsystems

- Inflammatix

Global and Japan PCR-based Enteric Disease Testing Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analyzers/Instruments
1.2.3 Kits/Panels
1.3 Market by Application
1.3.1 Global PCR-based Enteric Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clostridium Difficile
1.3.3 Campylobacteriosis
1.3.4 Cholera
1.3.5 E. coli Infection
1.3.6 H. pylori Infection
1.3.7 Salmonellosis
1.3.8 Shigellosis
1.3.9 Rotavirus Infection
1.3.10 Norovirus Infection
1.3.11 Parasitic Enteric Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PCR-based Enteric Disease Testing Market Perspective (2016-2027)
2.2 PCR-based Enteric Disease Testing Growth Trends by Regions
2.2.1 PCR-based Enteric Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 PCR-based Enteric Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 PCR-based Enteric Disease Testing Industry Dynamic
2.3.1 PCR-based Enteric Disease Testing Market Trends
2.3.2 PCR-based Enteric Disease Testing Market Drivers
2.3.3 PCR-based Enteric Disease Testing Market Challenges
2.3.4 PCR-based Enteric Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR-based Enteric Disease Testing Players by Revenue
3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2016-2021)
3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue
3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio
3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2020
3.5 PCR-based Enteric Disease Testing Key Players Head office and Area Served
3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service
3.7 Date of Enter into PCR-based Enteric Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR-based Enteric Disease Testing Breakdown Data by Type
4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2016-2021)
4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2022-2027)
5 PCR-based Enteric Disease Testing Breakdown Data by Application
5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America PCR-based Enteric Disease Testing Market Size (2016-2027)
6.2 North America PCR-based Enteric Disease Testing Market Size by Type
6.2.1 North America PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
6.2.2 North America PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
6.2.3 North America PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
6.3 North America PCR-based Enteric Disease Testing Market Size by Application
6.3.1 North America PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
6.3.2 North America PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
6.3.3 North America PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
6.4 North America PCR-based Enteric Disease Testing Market Size by Country
6.4.1 North America PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
6.4.2 North America PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe PCR-based Enteric Disease Testing Market Size (2016-2027)
7.2 Europe PCR-based Enteric Disease Testing Market Size by Type
7.2.1 Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
7.2.2 Europe PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
7.2.3 Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
7.3 Europe PCR-based Enteric Disease Testing Market Size by Application
7.3.1 Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
7.4 Europe PCR-based Enteric Disease Testing Market Size by Country
7.4.1 Europe PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type
8.2.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application
8.3.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region
8.4.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PCR-based Enteric Disease Testing Market Size (2016-2027)
9.2 Latin America PCR-based Enteric Disease Testing Market Size by Type
9.2.1 Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
9.2.2 Latin America PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
9.2.3 Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
9.3 Latin America PCR-based Enteric Disease Testing Market Size by Application
9.3.1 Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
9.4 Latin America PCR-based Enteric Disease Testing Market Size by Country
9.4.1 Latin America PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type
10.2.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application
10.3.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country
10.4.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Vela Diagnostics
11.2.1 Vela Diagnostics Company Details
11.2.2 Vela Diagnostics Business Overview
11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction
11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.2.5 Vela Diagnostics Recent Development
11.3 CorisBioconcept
11.3.1 CorisBioconcept Company Details
11.3.2 CorisBioconcept Business Overview
11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction
11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.3.5 CorisBioconcept Recent Development
11.4 Meridian Life Science
11.4.1 Meridian Life Science Company Details
11.4.2 Meridian Life Science Business Overview
11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction
11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.4.5 Meridian Life Science Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction
11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Abbott (ALERE)
11.6.1 Abbott (ALERE) Company Details
11.6.2 Abbott (ALERE) Business Overview
11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction
11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.6.5 Abbott (ALERE) Recent Development
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Details
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction
11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.7.5 bioMerieux SA Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Details
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction
11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.8.5 Trinity Biotech Recent Development
11.9 DiaSorin Molecular
11.9.1 DiaSorin Molecular Company Details
11.9.2 DiaSorin Molecular Business Overview
11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction
11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.9.5 DiaSorin Molecular Recent Development
11.10 Etta Healthcare (Ovagene Oncology)
11.10.1 Etta Healthcare (Ovagene Oncology) Company Details
11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview
11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction
11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.10.5 Etta Healthcare (Ovagene Oncology) Recent Development
11.11 ExcitePCR (PositiveID Corporation)
11.11.1 ExcitePCR (PositiveID Corporation) Company Details
11.11.2 ExcitePCR (PositiveID Corporation) Business Overview
11.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction
11.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.11.5 ExcitePCR (PositiveID Corporation) Recent Development
11.12 Flow Alliance
11.12.1 Flow Alliance Company Details
11.12.2 Flow Alliance Business Overview
11.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction
11.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.12.5 Flow Alliance Recent Development
11.13 Fluid-Screen
11.13.1 Fluid-Screen Company Details
11.13.2 Fluid-Screen Business Overview
11.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction
11.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.13.5 Fluid-Screen Recent Development
11.14 FluimediX
11.14.1 FluimediX Company Details
11.14.2 FluimediX Business Overview
11.14.3 FluimediX PCR-based Enteric Disease Testing Introduction
11.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.14.5 FluimediX Recent Development
11.15 Fluxergy
11.15.1 Fluxergy Company Details
11.15.2 Fluxergy Business Overview
11.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction
11.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.15.5 Fluxergy Recent Development
11.16 Focus Diagnostics (DiaSorin Molecular)
11.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details
11.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview
11.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction
11.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development
11.17 Future Horizon Scientific
11.17.1 Future Horizon Scientific Company Details
11.17.2 Future Horizon Scientific Business Overview
11.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction
11.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.17.5 Future Horizon Scientific Recent Development
11.18 Genalyte
11.18.1 Genalyte Company Details
11.18.2 Genalyte Business Overview
11.18.3 Genalyte PCR-based Enteric Disease Testing Introduction
11.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.18.5 Genalyte Recent Development
11.18 GeneFluidics
11.25.1 GeneFluidics Company Details
11.25.2 GeneFluidics Business Overview
11.25.3 GeneFluidics PCR-based Enteric Disease Testing Introduction
11.25.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.25.5 GeneFluidics Recent Development
11.20 GenSpeed Biotech
11.20.1 GenSpeed Biotech Company Details
11.20.2 GenSpeed Biotech Business Overview
11.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction
11.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.20.5 GenSpeed Biotech Recent Development
11.21 Gulf Bio Analytical
11.21.1 Gulf Bio Analytical Company Details
11.21.2 Gulf Bio Analytical Business Overview
11.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction
11.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.21.5 Gulf Bio Analytical Recent Development
11.22 Hahn-Schickard
11.22.1 Hahn-Schickard Company Details
11.22.2 Hahn-Schickard Business Overview
11.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction
11.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.22.5 Hahn-Schickard Recent Development
11.23 Helvoet
11.23.1 Helvoet Company Details
11.23.2 Helvoet Business Overview
11.23.3 Helvoet PCR-based Enteric Disease Testing Introduction
11.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.23.5 Helvoet Recent Development
11.24 HemoCue
11.24.1 HemoCue Company Details
11.24.2 HemoCue Business Overview
11.24.3 HemoCue PCR-based Enteric Disease Testing Introduction
11.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.24.5 HemoCue Recent Development
11.25 Danaher
11.25.1 Danaher Company Details
11.25.2 Danaher Business Overview
11.25.3 Danaher PCR-based Enteric Disease Testing Introduction
11.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.25.5 Danaher Recent Development
11.26 IDEX Health&Science
11.26.1 IDEX Health&Science Company Details
11.26.2 IDEX Health&Science Business Overview
11.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction
11.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.26.5 IDEX Health&Science Recent Development
11.27 iLine Microsystems
11.27.1 iLine Microsystems Company Details
11.27.2 iLine Microsystems Business Overview
11.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction
11.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.27.5 iLine Microsystems Recent Development
11.28 Inflammatix
11.28.1 Inflammatix Company Details
11.28.2 Inflammatix Business Overview
11.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction
11.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2016-2021)
11.28.5 Inflammatix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analyzers/Instruments
Table 3. Key Players of Kits/Panels
Table 4. Global PCR-based Enteric Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global PCR-based Enteric Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global PCR-based Enteric Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global PCR-based Enteric Disease Testing Market Share by Regions (2016-2021)
Table 8. Global PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global PCR-based Enteric Disease Testing Market Share by Regions (2022-2027)
Table 10. PCR-based Enteric Disease Testing Market Trends
Table 11. PCR-based Enteric Disease Testing Market Drivers
Table 12. PCR-based Enteric Disease Testing Market Challenges
Table 13. PCR-based Enteric Disease Testing Market Restraints
Table 14. Global PCR-based Enteric Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global PCR-based Enteric Disease Testing Market Share by Players (2016-2021)
Table 16. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR-based Enteric Disease Testing as of 2020)
Table 17. Ranking of Global Top PCR-based Enteric Disease Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by PCR-based Enteric Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service
Table 21. Date of Enter into PCR-based Enteric Disease Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2016-2021)
Table 25. Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global PCR-based Enteric Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2016-2021)
Table 29. Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product
Table 64. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Vela Diagnostics Company Details
Table 67. Vela Diagnostics Business Overview
Table 68. Vela Diagnostics PCR-based Enteric Disease Testing Product
Table 69. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 70. Vela Diagnostics Recent Development
Table 71. CorisBioconcept Company Details
Table 72. CorisBioconcept Business Overview
Table 73. CorisBioconcept PCR-based Enteric Disease Testing Product
Table 74. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 75. CorisBioconcept Recent Development
Table 76. Meridian Life Science Company Details
Table 77. Meridian Life Science Business Overview
Table 78. Meridian Life Science PCR-based Enteric Disease Testing Product
Table 79. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 80. Meridian Life Science Recent Development
Table 81. Bio-Rad Laboratories Company Details
Table 82. Bio-Rad Laboratories Business Overview
Table 83. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product
Table 84. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 85. Bio-Rad Laboratories Recent Development
Table 86. Abbott (ALERE) Company Details
Table 87. Abbott (ALERE) Business Overview
Table 88. Abbott (ALERE) PCR-based Enteric Disease Testing Product
Table 89. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 90. Abbott (ALERE) Recent Development
Table 91. bioMerieux SA Company Details
Table 92. bioMerieux SA Business Overview
Table 93. bioMerieux SA PCR-based Enteric Disease Testing Product
Table 94. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 95. bioMerieux SA Recent Development
Table 96. Trinity Biotech Company Details
Table 97. Trinity Biotech Business Overview
Table 98. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 99. Trinity Biotech Recent Development
Table 100. DiaSorin Molecular Company Details
Table 101. DiaSorin Molecular Business Overview
Table 102. DiaSorin Molecular PCR-based Enteric Disease Testing Product
Table 103. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 104. DiaSorin Molecular Recent Development
Table 105. Etta Healthcare (Ovagene Oncology) Company Details
Table 106. Etta Healthcare (Ovagene Oncology) Business Overview
Table 107. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product
Table 108. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 109. Etta Healthcare (Ovagene Oncology) Recent Development
Table 110. ExcitePCR (PositiveID Corporation) Company Details
Table 111. ExcitePCR (PositiveID Corporation) Business Overview
Table 112. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product
Table 113. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 114. ExcitePCR (PositiveID Corporation) Recent Development
Table 115. Flow Alliance Company Details
Table 116. Flow Alliance Business Overview
Table 117. Flow Alliance PCR-based Enteric Disease Testing Product
Table 118. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 119. Flow Alliance Recent Development
Table 120. Fluid-Screen Company Details
Table 121. Fluid-Screen Business Overview
Table 122. Fluid-Screen PCR-based Enteric Disease Testing Product
Table 123. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 124. Fluid-Screen Recent Development
Table 125. FluimediX Company Details
Table 126. FluimediX Business Overview
Table 127. FluimediX PCR-based Enteric Disease Testing Product
Table 128. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 129. FluimediX Recent Development
Table 130. Fluxergy Company Details
Table 131. Fluxergy Business Overview
Table 132. Fluxergy PCR-based Enteric Disease Testing Product
Table 133. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 134. Fluxergy Recent Development
Table 135. Focus Diagnostics (DiaSorin Molecular) Company Details
Table 136. Focus Diagnostics (DiaSorin Molecular) Business Overview
Table 137. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product
Table 138. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 139. Focus Diagnostics (DiaSorin Molecular) Recent Development
Table 140. Future Horizon Scientific Company Details
Table 141. Future Horizon Scientific Business Overview
Table 142. Future Horizon Scientific PCR-based Enteric Disease Testing Product
Table 143. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 144. Future Horizon Scientific Recent Development
Table 145. Genalyte Company Details
Table 146. Genalyte Business Overview
Table 147. Genalyte PCR-based Enteric Disease Testing Product
Table 148. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 149. Genalyte Recent Development
Table 150. GeneFluidics Company Details
Table 151. GeneFluidics Business Overview
Table 152. GeneFluidics PCR-based Enteric Disease Testing Product
Table 153. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2016-2021) & (US$ Million)
Table 154. GeneFluidics Recent Development
Table 155. GenSpeed Biotech Company Details
Table 156. GenSpeed Biotech Business Overview
Table 157. GenSpeed Biotech PCR
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs